{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:57:44Z","timestamp":1784098664745,"version":"3.55.0"},"reference-count":37,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T00:00:00Z","timestamp":1659571200000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["#D43TW009345"],"award-info":[{"award-number":["#D43TW009345"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["NIH\/NIAID K23AI120793"],"award-info":[{"award-number":["NIH\/NIAID K23AI120793"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR000423"],"award-info":[{"award-number":["UL1TR000423"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Int AIDS Soc."],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Isoniazid preventive therapy (IPT) can reduce the risk of tuberculosis (TB) in children living with HIV (CLHIV), but data on the outcomes of the IPT cascade in CLHIV are limited.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We evaluated the IPT cascade among CLHIV aged &lt;15 years and newly enrolled in HIV care in eight HIV clinics in western Kenya. Medical record data were abstracted from September 2015 through July 2019. We assessed the proportion of CLHIV completing TB symptom screening, IPT eligibility assessment, IPT initiation and completion. TB incidence rate was calculated stratified by IPT initiation and completion status. Risk factors for IPT non\u2010initiation and non\u2010completion were assessed using Poisson regression with generalized linear models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Overall, 856 CLHIV were newly enrolled in HIV care, of whom 98% ([95% CI 97\u201399]; <jats:italic>n<\/jats:italic> = 841) underwent screening for TB symptoms and IPT eligibility. Of these, 13 (2%; 95% CI 1\u20133) were ineligible due to active TB and 828 (98%; 95% CI 97\u201399) were eligible. Five hundred and fifty\u2010nine (68%; 95% CI 64\u201371) of eligible CLHIV initiated IPT; median time to IPT initiation was 3.6 months (interquartile range [IQR] 0.5\u201310.2). Overall, 434 (78%; 95% CI 74\u201381) IPT initiators completed. Attending high\u2010volume HIV clinics (aRR = 2.82; 95% CI 1.20\u20136.62) was independently associated with IPT non\u2010initiation. IPT non\u2010initiation had a trend of being higher among those enrolled in the period 2017\u20132019 versus 2015\u20132016 (aRR = 1.91; 0.98\u20133.73) and those who were HIV virally non\u2010suppressed (aRR = 1.90; 95% CI 0.98\u20133.71). Being enrolled in 2017\u20132019 versus 2015\u20132016 (aRR = 1.40; 1.01\u20131.96) was independently associated with IPT non\u2010completion. By 24 months after IPT screening, TB incidence was four\u2010fold higher among eligible CLHIV who never initiated (8.1 per 1000 person years [PY]) compared to CLHIV who completed IPT (2.1 per 1000 PY; rate ratio [RR] = 3.85; 95% CI 1.08\u201317.15), with a similar trend among CLHIV who initiated but did not complete IPT (8.2\/1000 PY; RR = 4.39; 95% CI 0.82\u201323.56).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Despite high screening for eligibility, timely IPT initiation and completion were suboptimal among eligible CLHIV in this programmatic cohort. Targeted programmatic interventions are needed to address these drop\u2010offs from the IPT cascade by ensuring timely IPT initiation after ruling out active TB and enhancing completion of the 6\u2010month course to reduce TB in CLHIV.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jia2.25939","type":"journal-article","created":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T04:18:35Z","timestamp":1659673115000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Drop\u2010offs in the isoniazid preventive therapy cascade among children living with HIV in western Kenya, 2015\u20132019"],"prefix":"10.1002","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1634-0531","authenticated-orcid":false,"given":"Dickens Otieno","family":"Onyango","sequence":"first","affiliation":[{"name":"Kisumu County Department of Health  Kisumu Kenya"},{"name":"Institute of Tropical Medicine  Antwerp Belgium"},{"name":"Julius Global Health, Julius Center for Health Sciences and Primary Care University Medical Center Utrecht  Utrecht the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne A. B.","family":"van der Sande","sequence":"additional","affiliation":[{"name":"Institute of Tropical Medicine  Antwerp Belgium"},{"name":"Julius Global Health, Julius Center for Health Sciences and Primary Care University Medical Center Utrecht  Utrecht the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney M.","family":"Yuen","sequence":"additional","affiliation":[{"name":"Harvard Medical School  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerphason","family":"Mecha","sequence":"additional","affiliation":[{"name":"Department of Research and Programs Kenyatta National Hospital  Nairobi Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Matemo","sequence":"additional","affiliation":[{"name":"Department of Research and Programs Kenyatta National Hospital  Nairobi Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Oele","sequence":"additional","affiliation":[{"name":"Kisumu County Department of Health  Kisumu Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kinuthia","sequence":"additional","affiliation":[{"name":"Department of Research and Programs Kenyatta National Hospital  Nairobi Kenya"},{"name":"Department of Global Health University of Washington  Seattle Washington USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"John\u2010Stewart","sequence":"additional","affiliation":[{"name":"Department of Global Health University of Washington  Seattle Washington USA"},{"name":"Division of Allergy and Infectious Diseases Department of Medicine, University of Washington  Seattle Washington USA"},{"name":"Department of Epidemiology University of Washington  Seattle Washington USA"},{"name":"Department of Pediatrics University of Washington  Seattle Washington USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9809-5997","authenticated-orcid":false,"given":"Sylvia M.","family":"LaCourse","sequence":"additional","affiliation":[{"name":"Department of Global Health University of Washington  Seattle Washington USA"},{"name":"Division of Allergy and Infectious Diseases Department of Medicine, University of Washington  Seattle Washington USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,8,4]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0237904"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000802"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11082-8"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1086\/651490"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0209098"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2018.05.017"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-91"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30216-X"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001461"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182185"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0234588"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.5588\/pha.13.0013"},{"key":"e_1_2_12_14_1","unstructured":"Ministry of Health 2020 National Tuberculosis Leprosy and Lung Disease Program Nairobi"},{"key":"e_1_2_12_15_1","unstructured":"National AIDS and STI Control Programme (NASCOP). Preliminary KENPHIA 2018 Report.Nairobi:NASCOP;2020."},{"key":"e_1_2_12_16_1","unstructured":"Ministry of Health 2015"},{"key":"e_1_2_12_17_1","unstructured":"Ministry of Health 2021"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.5588\/pha.20.0005"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003703"},{"key":"e_1_2_12_20_1","unstructured":"World Health Organization. The end TB strategy.2021."},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248115"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-021-10929-z"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05011-9"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.24248\/eahrj.v3i2.611"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000806"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212035"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-016-3525-8"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-024286"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/jpc.14359"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05471-z"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000791"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000391022.95412.a6"},{"key":"e_1_2_12_33_1","first-page":"133","article-title":"Outcome of isoniazid preventive therapy in adults living with HIV in Penang, Malaysia","volume":"4","author":"Lim CL","year":"2016","journal-title":"J Infect Dis Prev Med"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0200242"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1086\/520983"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00395-2018"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142290"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001879"}],"container-title":["Journal of the International AIDS Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jia2.25939","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jia2.25939","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jia2.25939","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T03:05:42Z","timestamp":1692759942000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jia2.25939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["10.1002\/jia2.25939"],"URL":"https:\/\/doi.org\/10.1002\/jia2.25939","archive":["Portico"],"relation":{},"ISSN":["1758-2652","1758-2652"],"issn-type":[{"value":"1758-2652","type":"print"},{"value":"1758-2652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"2021-10-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e25939"}}